Current attempts at preventing infections caused by group B Neisseria
meningitidis are largely directed on generating immune responses to ou
ter membrane proteins or the lipopolysaccharide of this organism. We s
uggest an alternative approach: the use of a live, attenuated strain o
f Neisseria meningitidis which could be delivered mucosally to elicit
both local and systemic immune responses. (C) 1998 Elsevier Science Lt
d. All rights reserved.